Novo, Novartis and Amgen all recorded exits as blood disorder therapeutics developer Ra floated in the middle of its range.

Stanford University spinout iRhythm, which had raised a total of $115.5m in equity and debt, has gone public in a $107m initial public offering.

The Novo, St. Jude and Kaiser Permanente-backed cardiac diagnostics technology developer floated above its range and closed its first day of trading 53% up on its IPO price.

Bayer invested $35m in the Switzerland-based gene editing company but it floated below its range and lowered the number of shares in the offering.

Pain assessment technology developer ePat is set to list on the Australian Stock Exchange today, providing an exit to Curtin University.

The advanced electrocardiogram developer, spun out of Stanford University, has set the range for an initial public offering sized at up to $91m.

Shareholders in the semiconductor memory technology provider include Western Digital and GlobalFoundries, while GigaDevice Semiconductor is investing $5m.

The gastric balloon developer has gone public, after raising more than $70m in debt and equity from investors including Bader Sultan & Bros and AmorePacific.

The cloud enterprise platform, backed by Sapphire Ventures, is set to make its debut on Nasdaq today after securing nearly $238m in an initial public offering yesterday.

China-based data analysis software producer Gridsum Holding has floated in the US, giving exits to Nokia Growth Partners and Disney affiliate Steamboat Ventures.